Abstract
E2F is a family of transcription factors implicated in cell cycle control. To understand the role of E2F in controlling cell cycle progression, it is necessary to clarify the breadth of the E2F family. To date, seven E2F subunits have been identified. We report here the characterization of a new E2F subunit, E2F-8, which resembles the organization of E2F-7 in the presence of two separate DNA-binding domains, the integrity of which is required for E2F-8 to bind to DNA. Furthermore, like E2F-7, we find that E2F-8 can repress transcription and delay cell cycle progression. The similarities between E2F-7 and E2F-8 define a new subgroup of the E2F family, and further imply that E2F-7 and E2F-8 may act through overlapping mechanisms in mediating cell cycle control.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blattner C, Sparks A and Lane D . (1999). Mol. Cell. Biol., 19, 3704–3713.
Chan HM, Smith L and La Thangue NB . (2001). Oncogene, 20, 6152–6163.
DeBruin A, Maiti B, Jakoi L, Timmers C and Leone G . (2003). J. Biol. Chem., 10, 42041–42049.
Di Stefano L, Rugaard Jensen M and Helin K . (2003). EMBO J., 23, 6289–6298.
Dyson N . (1998). Genes Dev., 12, 2245–2262.
Hanahan D and Weinberg R . (2000). Cell, 100, 57–70.
Kosugi S and Ohashi Y . (2002). J. Biol. Chem., 277, 16553–16558.
Logan N, Delavaine L, Graham A, Reilly C, Wilson J, Brummelkamp TR, Hijmans EM, Bernards R and La Thangue NB . (2004). Oncogene, 23, 5138–5150.
Moroni MC, Hickman ES, Denchi EL, Capara G, Colli E, Cecconi F, Müller H and Helin K . (2001). Nat. Cell Biol., 3, 552–558.
Stevens C and La Thangue NB . (2003a). Arch. Biochem. Biophys., 412, 157–169.
Stevens C and La Thangue NB . (2003b). DNA Repair, 3, 1071–1079.
Stevens C, Smith L and La Thangue NB . (2003). Nat. Cell Biol., 5, 401–409.
Trimarchi JM and Lees JA . (2002). Nat. Rev. Mol. Cell. Biol., 3, 11–20.
Vlieghe K, Boudolf V, Beemster GT, Maes S, Magyar Z, Atanassova A, de Almeida Engler J, De Groodt R, Inze D and Veylder L . (2005). Curr. Biol., 15, 59–63.
Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E and Dyson N . (1996). Cell, 85, 537–547.
Zhao X, McKillop-Smith and Muller B . (2004). J. Cell Sci., 117, 6043–6051.
Zheng N, Fraenkel E, Pabo CO and Pavletich NP . (1999). Gens Dev., 13, 666–674.
Acknowledgements
We thank Marie Caldwell for help in preparing this paper, and the MRC, CRUK and EU for supporting our research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Logan, N., Graham, A., Zhao, X. et al. E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7. Oncogene 24, 5000–5004 (2005). https://doi.org/10.1038/sj.onc.1208703
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208703
Keywords
This article is cited by
-
Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema
EMBO Molecular Medicine (2024)
-
The broken cycle: E2F dysfunction in cancer
Nature Reviews Cancer (2019)
-
Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas
Scientific Reports (2017)
-
Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer
Oncogene (2017)
-
E2F1: a promising regulator in ovarian carcinoma
Tumor Biology (2016)